Biology:LEKTI-2
 Generic protein structure example |
Lympho-epithelial Kazal-type related inhibitor 2 (LEKTI-2) is a protein encoded by the SPINK9 gene in humans. SPINK9 is a member of a gene family cluster located on chromosome 5q33.1, which includes SPINK5 and SPINK6.[1] LEKTI-2 is an inhibitor of KLK5.
Desquamation
The outer layer of the epidermis is called the stratum corneum. In the stratum corneum terminally differentiated corneocytes are held together by corneodesmosomes. In order for desquamation to occur, corneodesmosomes need to be fully degraded. KLK5 and KLK7 are two serine proteases that degrade corneodesmosomes. LEKTI-2 regulates corneodesmosome degradation by inhibiting KLK5. In acral (palm and sole) skin, where desquamation needs to be delayed, SPINK9 expression is strongly upregulated.[2] The resulting high level of LEKTI-2 delays corneodesmosome degradation, thereby allowing the epidermis to form a thick protective stratum corneum layer.[2]
Clinical Significance
SPINK9 is overexpressed in lichen simplex chronicus, actinic keratosis, and squamous cell carcinoma.[3]
See also
- Kazal-type serine protease inhibitor domain
References
- ↑ "When activity requires breaking up: LEKTI proteolytic activation cascade for specific proteinase inhibition". The Journal of Investigative Dermatology 131 (11): 2169–2173. November 2011. doi:10.1038/jid.2011.295. PMID 21997416.
- ↑ 2.0 2.1 "Biogeographic and disease-specific alterations in epidermal lipid composition and single-cell analysis of acral keratinocytes". JCI Insight 7 (16): e159762. August 2022. doi:10.1172/jci.insight.159762. PMID 35900871.
- ↑ "The serine protease inhibitor of Kazal-type 9 (SPINK9) is expressed in lichen simplex chronicus, actinic keratosis and squamous cell carcinoma". Archives of Dermatological Research 308 (2): 133–137. March 2016. doi:10.1007/s00403-015-1616-5. PMID 26746658.
 |  |
